1. Home
  2. ACHV vs CRT Comparison

ACHV vs CRT Comparison

Compare ACHV & CRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACHV
  • CRT
  • Stock Information
  • Founded
  • ACHV N/A
  • CRT 1991
  • Country
  • ACHV Canada
  • CRT United States
  • Employees
  • ACHV N/A
  • CRT N/A
  • Industry
  • ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • CRT Oil & Gas Production
  • Sector
  • ACHV Health Care
  • CRT Energy
  • Exchange
  • ACHV Nasdaq
  • CRT Nasdaq
  • Market Cap
  • ACHV 72.5M
  • CRT 65.1M
  • IPO Year
  • ACHV N/A
  • CRT 1992
  • Fundamental
  • Price
  • ACHV $3.58
  • CRT $9.95
  • Analyst Decision
  • ACHV Strong Buy
  • CRT
  • Analyst Count
  • ACHV 3
  • CRT 0
  • Target Price
  • ACHV $14.33
  • CRT N/A
  • AVG Volume (30 Days)
  • ACHV 234.9K
  • CRT 25.1K
  • Earning Date
  • ACHV 05-13-2025
  • CRT 01-01-0001
  • Dividend Yield
  • ACHV N/A
  • CRT 9.16%
  • EPS Growth
  • ACHV N/A
  • CRT N/A
  • EPS
  • ACHV N/A
  • CRT 0.99
  • Revenue
  • ACHV N/A
  • CRT $6,834,116.00
  • Revenue This Year
  • ACHV N/A
  • CRT N/A
  • Revenue Next Year
  • ACHV N/A
  • CRT N/A
  • P/E Ratio
  • ACHV N/A
  • CRT $10.02
  • Revenue Growth
  • ACHV N/A
  • CRT N/A
  • 52 Week Low
  • ACHV $1.84
  • CRT $8.88
  • 52 Week High
  • ACHV $5.58
  • CRT $14.40
  • Technical
  • Relative Strength Index (RSI)
  • ACHV 69.97
  • CRT 42.89
  • Support Level
  • ACHV $2.89
  • CRT $9.95
  • Resistance Level
  • ACHV $3.32
  • CRT $10.70
  • Average True Range (ATR)
  • ACHV 0.25
  • CRT 0.23
  • MACD
  • ACHV 0.06
  • CRT 0.02
  • Stochastic Oscillator
  • ACHV 95.12
  • CRT 17.07

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

About CRT Cross Timbers Royalty Trust

Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.

Share on Social Networks: